Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients
Status:
Unknown status
Trial end date:
2020-07-30
Target enrollment:
Participant gender:
Summary
Chronic hepatitis C virus infection affects an estimated one hundred and seventy million
people around the world with and approximate prevalence 0.2-2 % in the United State of
America and European countries.